Blood hormone monitoring in controlled ovarian stimulation

Dear friends and colleagues,

Due to changes in monitoring patients that may be attributed to the coronavirus pandemic, we would like to get input on your current practice of blood hormone monitoring during ART treatment. We would appreciate if you could spare a minute or two to answer a few short survey questions on the topic.

It is important to emphasize that the survey covers only current practice, such as what blood hormone monitoring you perform, as well as when and how often – during treatment using controlled ovarian stimulation for ART.

We hope we can count on your support of this initiative; we will publish findings openly following survey evaluation.

Thank you for your participation.
Warm regards,

Antonio Requena, Nikolaos Polyzos, Roger Hart, Vanessa Vergara  

All the requested personal data is used solely to verify submitter authenticity and will be preserved under the privacy policy of the European Union General Data Protection Regulation (GDPR). It will not be shared with any third party.

This survey is sponsored and financially supported by Merck KGaA. Merck KGaA selected the topic of the survey.